Unveiling Novel Urease Inhibitors for Helicobacter pylori: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25041968 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paulina Valenzuela-Hormazabal und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción 4030000, Chile. Hauptthemen laut MEDLINE: Helicobacter pylori. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANID FONDECYT de Iniciación, NLHPC, ANID FONDECYT Postdoctoral Project.
Abstract (Originalsprache)
Helicobacter pylori (Hp) infections pose a global health challenge demanding innovative therapeutic strategies by which to eradicate them. Urease, a key Hp virulence factor hydrolyzes urea, facilitating bacterial survival in the acidic gastric environment. In this study, a multi-methodological approach combining pharmacophore- and structure-based virtual screening, molecular dynamics simulations, and MM-GBSA calculations was employed to identify novel inhibitors for Hp urease (HpU). A refined dataset of 8,271,505 small molecules from the ZINC15 database underwent pharmacokinetic and physicochemical filtering, resulting in 16% of compounds for pharmacophore-based virtual screening. Molecular docking simulations were performed in successive stages, utilizing HTVS, SP, and XP algorithms. Subsequent energetic re-scoring with MM-GBSA identified promising candidates interacting with distinct urease variants. Lys219, a residue critical for urea catalysis at the urease binding site, can manifest in two forms, neutral (LYN) or carbamylated (KCX). Notably, the evaluated molecules demonstrated different interaction and energetic patterns in both protein variants. Further evaluation through ADMET predictions highlighted compounds with favorable pharmacological profiles, leading to the identification of 15 candidates. Molecular dynamics simulations revealed comparable structural stability to the control DJM, with candidates 5, 8 and 12 (CA5, CA8, and CA12, respectively) exhibiting the lowest binding free energies. These inhibitors suggest a chelating capacity that is crucial for urease inhibition. The analysis underscores the potential of CA5, CA8, and CA12 as novel HpU inhibitors. Finally, we compare our candidates with the chemical space of urease inhibitors finding physicochemical similarities with potent agents such as thiourea.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Farmacología, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción 4030000, Chile.
- Center for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andres Bello, Av. República 330, Santiago 8370146, Chile.
- Núcleo de Investigación en Data Science, Facultad de Ingeniería y Negocios, Universidad de las Américas, Santiago 7500000, Chile.
- Doctorado en Biotecnología Traslacional, Facultad de Ciencias Agrarias y Forestales, Universidad Católica del Maule, Talca 3480094, Chile.
- Biomedical Research Labs, Facultad de Medicina, Universidad Católica del Maule, Talca 3480094, Chile.
- Departamento de Química Física, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
ORCID-Profile: Paulina Valenzuela-Hormazabal, Romina V Sepúlveda, Reynier Suardíaz, Christian Galarza, Bruna Benso, Erix W Hernández-Rodríguez, Daniel Bustos
Förderung
- ANID FONDECYT de Iniciación
- NLHPC
- ANID FONDECYT Postdoctoral Project
- ANID FONDECYT Initiation Project
- RSC
- MCIN/AEI/10.13039/501100011033
Zitieren
APA
Valenzuela-Hormazabal, P., Sepúlveda, R. V., Alegría-Arcos, M., Valdés-Muñoz, E., Rojas-Pérez, V., González-Bonet, I., Suardíaz, R., Galarza, C., Morales, N., Leddermann, V., Castro, R. I., Benso, B., Urra, G., Hernández-Rodríguez, E. W., & Bustos, D. (2024). Unveiling Novel Urease Inhibitors for Helicobacter pylori: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25041968
Vancouver
Valenzuela-Hormazabal P, Sepúlveda RV, Alegría-Arcos M, Valdés-Muñoz E, Rojas-Pérez V, González-Bonet I, et al. Unveiling Novel Urease Inhibitors for Helicobacter pylori: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25041968
BibTeX
@article{ValenzuelaHormazabal2024,
author = {Valenzuela-Hormazabal, Paulina and Sepúlveda, Romina V and Alegría-Arcos, Melissa and Valdés-Muñoz, Elizabeth and Rojas-Pérez, Víctor and González-Bonet, Ileana and Suardíaz, Reynier and Galarza, Christian and Morales, Natalia and Leddermann, Verónica and Castro, Ricardo I and Benso, Bruna and Urra, Gabriela and Hernández-Rodríguez, Erix W and Bustos, Daniel},
title = {Unveiling Novel Urease Inhibitors for Helicobacter pylori: A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25041968}
}
EUVIMED